FDA Clearance Granted to Arineta’s Cardiac CT Scanner

tim.hodson

Mon, 05/19/2025 – 11:17

May 19, 2025 – Arineta, a provider of cardiovascular imaging solutions, recently announced that its SpotLight Duo cardiac CT scanner has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for low-dose lung cancer screening (LDCT). This clearance allows providers to use a single ultra-fast CT platform for both cardiac and lung imaging and diagnostics, delivering more complete care to high-risk patients.
Lung cancer is the le…

Read the full article on itnonline.com